Abiopharma

Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025

InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update

Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-08-07 AccNo: 0001654954-25-009162 Size: 29 KB

New Form 6-K - HUTCHMED Filed: 2025-08-07 AccNo: 0001410578-25-001583 Size: 13 MB

New Form 8-K - Aclaris Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001558370-25-010640 Size: 375 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - REGENXBIO Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174947 Size: 616 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - LENSAR, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104556 Size: 748 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Amylyx Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174948 Size: 8 MB

New Form 8-K - DENTSPLY SIRONA Inc. Filed: 2025-08-07 AccNo: 0000818479-25-000152 Size: 682 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - C4 Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038587 Size: 6 MB

New Form 8-K - IRONWOOD PHARMACEUTICALS INC Filed: 2025-08-07 AccNo: 0001104659-25-074972 Size: 477 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Celcuity Inc Notification (CELC)